1-(4-Chloro-3-fluoro-2-iodo-phenyl)-4-(trifluoromethyl)triazole, 98%, 500mg

1-tert-Butyl 3-methyl 3-allylpiperidine-1,3-dicarboxylate, 95.0%, 1g

2-Methyl-5-oxo-2,5-dihydro-1H-pyrazole-3-carboxylic acid, 97%, 100mg

1,2-Dibromoethylene (cis- and trans- mixture)>98.0%(GC)25g

(R)-2-(tert-Butoxycarbonyl)-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, 95.0%, 250mg

Sodium 5-isopropyl-3,8-dimethylazulene-1-sulfonate, 95.0%, 5g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)butanoic acid, 97%, 1g

1-(7,8-Diamino-1,2,4,5-tetrahydro-1,5-methano-3H-3-benzazepin-3-yl)-2,2,2-trifluoroethanone, 98%, 10g

(S)-Methyl 4-benzylmorpholine-3-carboxylate, 95.0%, 5g

4-(4-Methylthiazol-2-yl)phenol, 95+%, 10g

1-Benzyl 2-ethyl piperazine-1,2-dicarboxylate, 98%, 100mg

Accessories CP tips for sterile direct displacement pipettes, 50 to 250 µl, Estim. for, M250E, Rack (6 x 96), 576 Pieces

(S)-1-(3-Aminopyrrolidin-1-yl)-2-ethylbutan-1-one hydrochloride, 95.0%, 1g